CIBCX
Price
$72.57
Change
+$0.12 (+0.17%)
Updated
Apr 2 closing price
Net Assets
109.37B
HRLRX
Price
$9.00
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Net Assets
61.27M
Ad is loading...

CIBCX vs HRLRX

Header iconCIBCX vs HRLRX Comparison
Open Charts CIBCX vs HRLRXBanner chart's image
American Funds Capital Income Bldr C
Price$72.57
Change+$0.12 (+0.17%)
VolumeN/A
Net Assets109.37B
Hartford Real Asset R3
Price$9.00
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets61.27M
CIBCX vs HRLRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIBCX vs. HRLRX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIBCX is a Buy and HRLRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CIBCX has more cash in the bank: 109B vs. HRLRX (61.3M). HRLRX pays higher dividends than CIBCX: HRLRX (3.12) vs CIBCX (2.41). CIBCX was incepted earlier than HRLRX: CIBCX (24 years) vs HRLRX (15 years). HRLRX (1.87) is less costly to investors than CIBCX (1.34). HRLRX has a lower initial minimum investment than CIBCX: HRLRX (0) vs CIBCX (250). CIBCX annual gain was more profitable for investors over the last year : 9.38 vs. HRLRX (4.32). HRLRX return over 5 years is better than : 76.19 vs. CIBCX (52.75).
CIBCXHRLRXCIBCX / HRLRX
Total Expense Ratio1.341.5189%
Annual Report Gross Expense Ratio1.341.8772%
Fund Existence24 years15 years-
Gain YTD5.3008.56562%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets109B61.3M177,814%
Annual Yield % from dividends2.413.1277%
Returns for 1 year9.384.32217%
Returns for 3 years11.766.20190%
Returns for 5 years52.7576.1969%
Returns for 10 years35.4536.0098%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARS51.492.57
+5.25%
Tarsus Pharmaceuticals
RTC0.230.01
+4.48%
Baijiayun Group Ltd
GAIN13.530.07
+0.52%
Gladstone Investment Corp
ASND152.150.72
+0.47%
Ascendis Pharma A/S
STKH0.97-0.04
-3.96%
Steakholder Foods Ltd